Am J Transplant, Volume 21, Suppl 3 Archives - Page 102 of 139 - ATC Abstracts

2021 American Transplant Congress
Health-related Quality of Life (HRQoL) in Patients on Dialysis and Kidney Transplant Recipients – Experience with the PROMIS Global-10 Survey
G. Chawla, W. Hajjar, M. Dastgheib, N. Yanga, G. Ahmadzadeh, N. El-Dassouki, A. Shahreza, N. Al Kaabi, N. Edwards, I. Mucsi
University Health Network, Division of Nephrology and Multi-Organ Transplant Program, Toronto, ON, Canada
*Purpose: The PROMIS (Patient-Reported Outcomes Measurement Information System) Global-10 survey has been used to assess HRQoL in population surveys and studies including patients with chronic…
2021 American Transplant Congress
Information-Seeking Behavior During Covid-19: Opportunities for Communication and Care Transition Improvements
S. H. Advani¹, S. M. Advani², Y. A. Iraheta³, A. Murillo⁴, H. A. Gritsch³, A. D. Waterman³
¹Terasaki Institute, Bethesda, MD, ²National Human Genome Research Institute, Bethesda, MD, ³UCLA, Los Angeles, CA, ⁴Terasaki Institute, Los Angeles, CA
*Purpose: To learn more about how at-risk dialysis and transplant patients sought health information during COVID-19 and what was most helpful, we conducted a mixed-methods…
2021 American Transplant Congress
The Seattle Heart Failure Model is a Predictor of Mortality After Kidney Transplant in Patients with End Stage Renal Disease and Heart Impairment
A. Perez-Gutierrez¹, P. J. Bachul², D. N. Danz³, B. Juengel², M. Josephson², J. Fung², P. Witkowski², B. Chung⁴, Y. Becker²
¹Surgery, University of Chicago, Chicago, IL, IL, ²Surgery, University of Chicago, Chicago, IL, ³Economics, University of Pittsburgh, Pittsburgh, IL, ⁴Cardiology, University of Chicago, Chicago, IL
*Purpose: Cardiovascular disease is the main cause of mortality after kidney transplantation. Many patients with ESRD have heart failure that is attributed to fluid overload.…
2021 American Transplant Congress
Safety and Tolerability of Tacrolimus Extended-Release (astagraf Xl) in Hla Sensitized Kidney Transplant Recipients: A Single Center Experience
A. A. Vo, N. Ammerman, E. Huang, A. Peng, R. Najjar, S. Sethi, K. Lim, M. Gillespie, S. C. Jordan
Cedars Sinai Medical Ctr, Los Angeles, CA
*Purpose: Pill burden is a limitation in kidney transplant. Tacrolimus extended-release (Astagraf XL) is a once daily formulation approved for kidney transplantation. Increased compliance could…
2021 American Transplant Congress
Calcineurin Inhibitor Dose and Selection, Not Antiproliferatives or Steroids, Influence Development of DSA One Year Post-kidney Transplant
M. Henderson¹, G. Morris², L. Awdishu¹, K. Fabbri¹, M. Shah³, A. Khan³, J. Kerr¹
¹Pharmacy, University of California San Diego Health, San Diego, CA, ²Pathology, University of California San Diego Health, San Diego, CA, ³Nephrology, University of California San Diego Health, San Diego, CA
*Purpose: Allograft rejection is a serious complication in kidney transplantation (KT). Despite advances in immunosuppression, acute rejection remains a concern in the first year of…
2021 American Transplant Congress
Factors Affecting Sensitization Following Kidney Allograft Failure
N. Garg, L. Hidalgo, S. Parajuli, F. Aziz, M. Mohamed, A. Djamali, D. Mandelbrot
UW Madison, Madison, WI
*Purpose: Kidney transplant (KT) recipients with failed allografts constitute nearly 12% of the current waitlist in the US. Sensitization as a result of graft failure…
2021 American Transplant Congress
Identifying Health-System Level Barriers and Facilitators to Living Donor Kidney Transplantation: A Comparative Case Study
A. Horton¹, M. Fortin², P. Nugus³, D. Landsberg⁴, M. Paquet², M. Cantarovich¹, S. Sandal¹
¹Nephrology, McGill University Health Centre, Montreal, QC, Canada, ²Nephrology, Centre Hospitalier de l’Université de Montréal, Montreal, QC, Canada, ³Family Medicine, McGill University, Montreal, QC, Canada, ⁴Nephrology, University of British Columbia, Vancouver, BC, Canada
*Purpose: Despite the well-known advantages of living donor kidney transplantation (LDKT), rates at many centers have stagnated or declined. In Canada, there are large interprovincial…
2021 American Transplant Congress
The Experience of 1000 Hand Assisted Laparoscopic Donor Nephrectomy for Living Donor Kidney Transplantation
T. Hiramitsu¹, T. Tomosugi², K. Futamura², M. Okada², N. Goto², T. Ichimori², S. Narumi², Y. Watarai²
¹Nagoya Daini Red Cross Hospital, Myokencho Showaku, Japan, ²Nagoya Daini Red Cross Hospital, Nagoya, Japan
*Purpose: Due to the profound organ shortage, living donor kidney transplantation becomes more necessary. Hand assisted laparoscopic donor nephrectomy (HALDN) is widely performed to lessen…
2021 American Transplant Congress
Criteria and Practice Patterns for Accepting Living Donors with Prior Covid-19: A National Survey
A. Jawed¹, M. Y. Jan², N. Barros², O. Adebiyi², A. Diez³, J. Fridell², W. Goggins², M. Yaqub², M. A. Mujtaba⁴, T. Taber², V. Kumar⁵, K. Lentine⁶, A. Sharfuddin²
¹Wayne State University, Detroit, IN, ²Indiana University School of Medicine, Indianapolis, IN, ³The Ohio State University, Columbus, OH, ⁴UTMB Galveston, Galveston, TX, ⁵University of Alabama, Birmingham, AL, ⁶St. Louis University, St. Louis, MO
*Purpose: A critical question facing transplant programs is if, when and how to safely accept living kidney donors (LKD) who have a history and recovered…
2021 American Transplant Congress
Predictors of Prolonged Length of Stay in Pediatric Kidney Transplantation: Changes Over the Last Three Decades
K. Goli, N. T. Galvan, R. T. Cotton, J. A. Goss, C. A. O'Mahony, A. Rana
Department of Abdominal Transplantation, Baylor College of Medicine, Houston, TX
*Purpose: Hospital length of stay (LOS) following kidney transplantation, particularly prolonged LOS, has not shown much improvement since the early 2000s. This study explores changes…